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Summary 
To develop an animal model for antimyeloperoxidase (MPO)-associated necrotizing crescentic 
glomerulonephritis (NCGN),  we immunized Brown Norway rats with MPO and localized a 
neutrophil lysosomal enzyme extract, primarily consisting of MPO and elastinolytic enzymes, 
plus  H202,  the  substrate  of MPO,  to  the  glomerular basement  membrane (GBM).  Upon 
immunization rats developed antibodies and positive skin tests to MPO. After unilateral perfusion 
of the left kidney with the lysosomal enzyme extract and H202,  MPO and immunoglobulin 
(Ig)G localized transiently along the GMB.  At the time of maximal inflammation, at 4 and 
10 d after perfusion, MPO, IgG, and C3 could not be detected anymore. MPO-immunized rats 
perfused with the lysosomal enzyme extract and H202, in contrast to control-immunized and/or 
control-perfused rats, developed a proliferative GN characterized by intra- and extracapillary cell 
proliferation,  ruptured Bowman's capsule,  periglomerular granulomatous inflammation,  and 
formation of giant cells. Monocytes, polymorphonuclear leukocytes (PMN), and to a far lesser 
extent T cells were found in the glomeruli. Interstitial infiltrates consisted of monocytes, PMN, 
and T  cells. Granulomatous vasculitis  of small vessels was found at 10 d  after perfusion. The 
proliferative NCGN in this rat model closely resembles human anti-MPO-associated pauci-immune 
NCGN,  and enables the study of the pathophysiology of anti-MPO-associated NCGN. 
N 
'ecrotizing crescentic glomerulonephritis (NCGN), 1 a 
clinically rapidly progressive form of glomerular dis- 
ease, can be associated with multisystem disorders (infectious 
or noninfectious), or may occur in patients without a definite 
diagnosis of systemic illness (1). NCGN can be classified into 
three immunopathogenic categories: (a) anti-glomerular base- 
ment membrane (GBM) antibody mediated; (b) immune com- 
plex mediated; and (c) antineutrophil cytoplasmic antibody 
(ANCA)  associated  (2).  ANCA in patients with ANCA- 
associated NCGN  are either directed to proteinase 3 (Pr3) 
(3-5)  or myeloperoxidase (MPO)  (2,  6,  7),  both myeloid 
lysosomal enzymes. NCGN associated with anti-MPO anti- 
bodies is characterized by segmental fibrinoid necrosis of the 
GBM, marked infiltration of neutrophils and mononuclear 
cells, and paucity of IgG deposits (8-12). NCGN can be ac- 
companied by granuloma formation (13, 14). The pathogen- 
1 Abbreviations used in  this paper: ANCA, antineutrophil cytoplasmic 
antibody; GBM, glomerular  basement  membrane;  MPO, myeloperoxidase; 
NCGN, necrotizing crescentic  glomerulonephritis;  Pr3, proteinase 3. 
esis of ANCA-associated NCGN has not been elucidated so 
far. The close association between pauci-immune NCGN and 
anti-MPO antibodies (6, 7) suggests a pathogenetic role for 
an  anti-MPO-directed immune response.  In  vitro  studies 
showed that anti-MPO antibodies can activate PMN to cause 
a respiratory burst and to mediate degranulation (15). We 
hypothesized that NCGN may develop after focal release of 
lysosomal enzymes and production  of H202  by activated 
neutrophils in the presence of an anti-MPO-directed immune 
response. To test this hypothesis we developed an animal model 
in which we perfused a lysosomal enzyme extract and H202 
into the kidney of Brown-Norway (BN) rats immunized with 
MPO. BN rats were chosen because they develop both hu- 
moral and cellular responses to MPO. Rats immunized with 
MPO and perfused with the lysosomal enzyme extract and 
H202  were  found  to  develop  glomerular  intracapillary 
thrombosis followed by a proliferative glomerulonephritis 
characterized by glomerular capillary wall necrosis, extracapil- 
lary cell proliferation, infiltration of neutrophils and mono- 
cytes, ruptured Bowman's capsule, periglomerular granuloma 
formation, vasculitis,  and extensive interstitial mononuclear 
infiltrates. Ig deposits were absent or scanty, similar to human 
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of pauci-immune NCGN was found to be dependent on the 
presence of the lysosomal enzyme extract  and H202 along 
the GBM  and  a MPO-directed  immune response. 
Materials  and Methods 
Rats.  All experiments were performed in conventionally housed, 
3-too-old BN rats, fed ad libitum with standard chow (Hope Farms, 
Woerden, The Netherlands). 
Lysosomal Enzyme Extract.  Human PMN were isolated  from 
buffy coats on a Ficoll density gradient followed by dextran sedimen- 
tation.  After sedimentation  the remaining erythrocytes were re- 
moved by hypotonic lysis. MPO was extracted  from PMN by dis- 
solution of the ceUs in cetyltrimethyl ammonium bromide (CETAB) 
and sonification.  Nuclei and membrane fragments were discarded 
by ultracentrifugation and the extract was absorbed  to a Con A 
Sepharose gel and eluted with cr  Eluted frac- 
tions with a ratio (OD 428/280) ;>0.5, measured  as the ratio be- 
tween the OD obtained at 428 nm (showing a specific spectral band 
for MPO) and the OD obtained at 280 nm, were pooled and ex- 
tensively  dialyzed  to  sodium  acetate  buffer,  pH  6.0  (16). The 
resulting lysosomal  extract  had an OD 428/280 ratio  ~.5  and 
contained mainly MPO, Pr3, and trace amounts of elastase, but 
no tactoferrin as determined by sandwich ELISA (3). In accordance 
with the results of ELISA, specific bands for MPO (at 15, 39, 58 
kD) and Pr3 (at 30 kD) were found by gel electrophoresis  (results 
not shown).  Peroxidase activity of the extract was assayed spec- 
trophotometrically by measuring the increase in absorbance at 470 
nm upon oxidation of guaiacol  (Sigma Chemical Co., St.  Louis, 
MO). In brief,  10 ~1 of the MPO preparation was added to a 1-cm 
light path cuvette containing 3 ml of the assay solution. The solu- 
tion consisted  of 29.6  ml H20,  3 ml 0.1  M  sodium phosphate 
buffer,  pH 7.0,  0.1 ml 0.1 M  H202, and 48 #1 guaiacol.  1 U  of 
peroxidase activity is defined as the amount that consumes 1 #mol/ 
rain  of H202  (17). 100  /~g of the  lysosomal  extract  contained 
"~58/~g MPO with an  activity of 30 U. 
Myeloperoxidase.  Human  MPO was purchased  from Calbio- 
chem-Behring Co. (La Jolla, CA). This MPO was dissolved in so- 
dium acetate  buffer  and had  an  OD 428/280 ratio  ;>0.7. 
Immunization Procedure.  BN rats were immunized with human 
MPO in CFA supplemented  with H37Ra (5 mg/ml; Difco Labora- 
tories, Detroit, MI). Rats received 10 #g MPO or control solution 
without MPO (sodium acetate buffer)  subcutaneously in 0.2 ml 
at two sites near the tailbase. At different  intervals levels of anti- 
MPO antibodies  were measured  by ELISA. The cellular response 
was  assessed by skin  testing. 
Detection of Anti-MPO Antibodies by ELISA.  In short, Labstar 
(Greiner, Kremsmiinster, Austria) microtiter plates were coated over- 
night with human MPO (isolated as described before) at a protein 
concentration of 20 #g/ml in 0.1 M carbonate buffer, pH 9.6. The 
plates were incubated with rat plasma, diluted in 0.05 M Tris, 0.05% 
Tween, 2% BSA, and 0.3 M NaC1, pH 8.0,  starting at a dilution 
of 1:100 in PBS. Antibody binding was detected with sheep anti-rat 
Ig linked to alkaline phosphatase  (Serotec, Oxford, England), fol- 
lowed by p-nitrophenyl-phosphate-disodium  as a substrate. The OD 
was read at 405  nm,  and a standard  curve was prepared  from a 
reference serum. Antibody concentrations were computed from the 
linearized  titration curve obtained after log-logit transformation 
of the absorbances of the respective dilutions of the reference serum. 
The concentration of the reference serum was set at  100 U. The 
specificity of the antibodies  for MPO was confirmed by immuno- 
precipitation  from a total neutrophil extract. 
Detection of Anti-MPO by Immunoprecipitation.  Human PMN 
were isolated by Ficoll, and a crude granule extract was obtained 
by nitrogen cavitation and ureum extraction  in the presence of pro- 
tease inhibitors (3). Nuclei and membrane fragments were discarded 
by centrifugation. The antigens  were radiolabeled with nsI by the 
iodogen method (3), and diluted in PBS containing 4% BSA, 1% 
Triton X-100, 0.5% SDS, and 0.5 M NaC1 (immunoprecipitation 
[IPP] buffer). Antibody-bound antigen complexes were precipitated 
with protein A CL-4B (Pharmacia, Uppsala, Sweden), 5 rag/plasma 
sample, washed with IPP buffer, PBS, and 10 mM Tris-HC1, pH 
6.8, and centrifuged through a sucrose gradient. The samples were 
boiled for 1 rain in fl-mercaptoethanol/SDS and subjected to elec- 
trophoresis  in a 12.5%  acrylamide  gel. After electrophoresis,  gels 
were vacuum dried  and exposed  to a Kodak XAR5 film. 
Skin Tests.  To test the ceUular response to MPO, heat-inactivated 
human MPO was applied  to the inner ear pinna subcutaneously 
in MPO-immunized and control rats at 1, 5, and 10 wk after im- 
munization. All measurements were done in triplicate. The increase 
in ear thickness was measured with an engineer's micrometer (Tesa, 
Switzerland)  at  0,  4,  24,  and 48 h  after  application. 
Renal Perfusion.  Unilateral perfusion of the left kidney was per- 
formed according to a modification of the method of Hoyer et al. 
(18).  Rats  were  anesthesized  with  halothane,  02,  and  NO2. 
Through a midline incision,  the aorta and vena cava were exposed 
by blunt dissection.  After ligation of the tributaries,  temporary 
clamps were placed on the aorta above the left renal artery, leaving 
the circulation of the right renal artery undisturbed.  Through a 
puncture hole in the aorta, a needle was inserted  and advanced up 
to the level of the left renal artery.  The left renal vein was punc- 
tured to let blood and perfused fluids escape, which were collected 
in cotton wool. PBS (37~  pH 7.3) was infused until the kidney 
became pale and no visible blood escaped from the punctured renal 
vein. Subsequently 100 ~g of the lysosomal enzyme extract in 0.5 
ml PBS containing "~58 #g MPO with an activity of 30 U, or 
58/~g MPO alone in PBS, or PBS (see experimental  design) alone 
were perfused  for 1 min.  After an additional  exposure  time of 2 
rain the kidney was again  perfused  with PBS or with 2 ml PBS 
containing 1 mM H202 (nontoxic concentration)  followed by PBS 
according to Johnson et  al.  (19). After perfusion  the needle was 
removed, the aorta was closed with atraumatic sutures,  the clamps 
were removed, and the kidney was allowed to reperfuse. Total isch- 
emia time was always <12 min. Only rats were studied  in which 
the kidney regained normal perfusion and color. After surgery the 
rats were placed under a heat lamp for 2 h and received an injection 
with buprenorfine (Reckitt  and Coleman,  Hull,  England)  sub- 
cutaneously as a pain  reliever. 
For estimation of proteinuria, urine was collected in metabolic 
cages 24 h after perfusion from all rats and before the day of death 
at 4 and 10 d after perfusion.  The protein content was estimated 
with buprenorfine (Reckitt  and Coleman, Hull,  England)  sub- 
cutaneously as a pain  reliever. 
Histological Examination.  At different time intervals,  rats were 
perfused with PBS at 4~  to remove the blood from both kidneys 
and killed.  Specimens from both kidneys were obtained and pre- 
pared  for light  microscopy,  immunofluorescence,  and immuno- 
histochemistry.  For light microscopy, renal tissue was fixed in 2% 
paraformaldehyde/PBS and embedded in plastic. 4-/~m sections were 
stained  with hematoxylin-eosin, periodic  acid Schiff, or periodic 
acid  silver methamine.  For  immunofluorescence  (IF)  and  im- 
munoperoxidase staining  (IP),  material  was snap frozen in freon 
or isopenthane (isobutane),  and  2- and 4-#m sections  were cut. 
Sections were standard fixed with acetone. For detection of MPO, 
sections were fixed with acetone-buffered formalin,  9% (20). After 
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or swine serum, depending on the conjugate used.  Detection of 
MPO,  Ig, and complement was tested by IF using mouse anti- 
human  MPO  (Table  1),  rabbit  anti-rat  IgG/A/M,  F(ab')2 goat 
anti-rat IgG, and F(ab')2 goat anti-rat C3, respectively (all from 
Cappel Laboratories, West Chester, PA), followed by FITC-labeled 
conjugates. The following conjugates were used: rabbit anti-mouse 
FITC (Dakopatts, Glostrup, Denmark),  F(ab')z goat anti-rabbit 
FITC,  and  F(ab')~  rabbit  anti-goat  FITC  (both  from  Cappel 
Laboratories). Granulocytes, monocytes, and T cells were detected 
by IP using the mAbs ED1, His48, and OX19, respectively (Table 
1), followed by peroxidase (PO)-labeled conjugates. We used rabbit 
anti-mouse PO (Dakopatts) with aminoethylcarbimazole as a sub- 
strate. Endogenous peroxidase activity was blocked with 0.05% 
H202 in PBS. Sections were counterstained with hematoxylin. All 
necessary dilutions  were made in PBS, pH 7.2. The amount of MPO, 
IgG, and complement deposition was estimated on a semiquan- 
titative (3+) scale: -, absent; _% weak; +, mild; + +, intermediate; 
+ + +, strong. To estimate the number of EDl-, His48-, and OX19- 
positive  cells,  we  calculated  the  average  number  of cells  per 
glomerulus by counting all positive cells present within 50 glomeruli 
and dividing the total number by 50.  Interstitial leukocytes were 
quantified by using a semiquantative method:  -, absent;  _+, min- 
imal;  +,  mild;  ++,  moderate,  and  + ++,  severe.  For  im- 
munofluorescence, sections were scored by two blinded persons. 
Electron Microsco~.  Renal tissue was fixed in 2% paraformalde- 
hyde (PF), 0.05% glutaraldehyde in PBS, pH 7.3, at 4~  for 1 h. 
After fixation  tissue  was stored in  PBS, containing  1%  PF and 
1% sucrose. Before processing  sections of I mm  3 were cut and im- 
mersed in  50 mM NH4CI in PBS for 1 h  at 4~  The sections 
were dehydrated, alter several wash steps, by overnight incubation 
in  absolute ethanol  at progressively lowered  temperatures  (PLT 
method) ranging from 0  to  -35~  After dehydration  the sec- 
tions were infiltrated with Lowicryl (Bio-Rad Laboratories, Rich- 
mond, CA) at  -35~  Lowicryl was refreshed three times before 
the resin was allowed to polymerize under ultraviolet light (360 
nM) for 2 d at  -40~  followed by 2 d polymerization at room 
temperature (RT). 
Lowicryl ultrathin sections on formvar-coated nickel grids (200 
mesh) were floated on drops of 20/zl 5% normal goat serum/Tris- 
buffered saline  (TBS), pH 7.4.  Grids were washed four times in 
1% TBS/BSA by transferring  and floating on four droplets for 5 min 
each. The sections were subsequently incubated in 20-#1 droplets 
of the primary antiserum (anti-MPO or anti-IgG) for 2 h at RT 
in a humidity chamber. The antiserum was washed off with 1% 
TBS/BSA. The sections were then immersed in 20-/~1 droplets of 
goat anti-rabbit-labeled with  15 nm immuno-gold (Auroprobe, 
Amersham, UK) in 1% TBS/BSA, supplemented with 1% normal 
rat serum for 1 h at RT. After gold labeling, grids were washed 
with TBS/BSA (once for 5 min), TBS (twice for 5 min), and bidest 
(three times for 5 min).  The sections were counterstained with 
1.8% uranylacetate in 0.2%  methylcellulose (15 centipose) in bi- 
dest for 5 min. Specificity  of the staining was controlled by use 
of a mAb of the IgG1 subclass  directed against pollen. 
StatisticaIAnalysis.  All values are expressed as the mean _+ SEM 
and were analyzed for statistical differences by a nonparametric one- 
way analysis  of variance (anova)  for unpaired data.  Correlations 
within groups for different values were assessed with Spearman's 
rank correlation  test. 
Experimental Design.  Seven groups of experiments were per- 
formed according to the following design: (I) Renal perfusion with 
the lysosomal enzyme extract and H202 in MPO-immunized rats. 
The lysosomal enzyme extract and H202 were perfused into the 
left kidney in MPO-immunized rats,  5 wk after immunization. 
Rats were killed at 4 h (n  =  2), 24 h (n  =  3), 4 d (n  =  6), and 
10 d (n  =  8) after perfusion. (II) Renal perfusion with the lyso- 
somal enzyme extract and H202 in control-immunized rats.  The 
same procedure was followed for control-immunized rats as de- 
scribed in Exp. I. (III) Renal perfusion with the lysosomal enzyme 
extract in MPO-immunized rats. The same procedure was followed 
as  described  in  Exp.  I.  Rats were killed  at 4  h  (n  =  2),  24  h 
(n  =  2), 4 d (n  =  2), and 10 d (n  =  3) after perfusion. (IV) Renal 
perfusion with purified  MPO and H202 in MPO-immunized rats. 
The same procedure was followed as described in Exp. I. Rats were 
killed at4h(n  =  2),24h(n  =  2),4d(n  =  4),  and  10d(n 
=  4)  after perfusion.  (V) Renal perfusion with H202 in MPO- 
immunized rats.  The same procedure was followed as described 
in Exp I. Rats were killed at 10 d  (n  =  4)  after perfusion.  (VI) 
Renal perfusion with MPO in MPO-immunized rats.  The same 
procedure was followed as described in Exp.  I. Rats were killed 
at4h(n  =  2),24h(n  =  2),4d(n  =  2), and10 d  (n  =  2) 
after  perfusion.  (VII)  Renal  perfusion  with  MPO  in  control- 
immunized rats.  The same procedure was followed as described 
in  Exp.  VI. 
Results 
Humoral and Cellular  Immune Response  to MPO 
BN  rats  immunized  with  human  MPO  developed  anti- 
bodies reacting with MPO (Fig. 1). The antibodies specifically 
precipitated MPO from a crude granule extract. The precipi- 
tate shows the 58-kD  MPO heavy chain and a 39-kD  heat 
degradation  product.  The  polyclonal  anti-MPO  antibody 
(Table  1)  precipitated  the  same bands,  whereas control  rat 
plasma did not precipitate any granule proteins (Fig. 2). The 
skin  tests used  to document  the cellular response to MPO 
showed an increase in ear thickness developing from 4 to 24 h 
(Fig. 3) with a gradual decrease thereafter. Immunohistolog- 
ical examination of the ears at 24 h showed an infiltrate con- 
sisting of monocytes and neutrophils.  Control rats showed 
only a slight  increase in ear thickness  at 4  h,  probably due 
to a transient reaction to the injected MPO solution. For per- 
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Figure  1.  Development of anti-MPO antibody titers in five  representa- 
tive rats immunized with human MPO. Antibodies to human MPO were 
measured by ELISA at 0, 3, 6, and 9 wk after immunization. Results are 
expressed as arbitrary units. Negative controls were <5 U (mean _+ 2 SD). 
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Antigen 
Code  recognized  Ig(sub-)class  Specificity  Source 
MPO  Human MPO  Poly  PMN/monocytes  Dakopatts,  Glostrup,  Denmark 
4.15  Human MPO  IgG1  PMN/monocytes  CLB* 
ED1  Cytoplasmic  IgG1  Macrophages  Reference 30 
His 48  Membrane  IgG1  Neutrophils  Reference 31 
OX  19  CD5/69 kD  IgG1  T  cells/subpopulation  of B cells  Oxford* 
* Central Laboratory  for the Blood Transfusion Service, Amsterdam, The Netherlands. 
* MCR Cellular Immunology  Unit, William Dunn School of Pathology, University  of Oxford, Oxford, UK. 
fusion studies,  rats 5 wk postimmunization were used, i.e., 
at  a time when the humoral response was maximal. 
Renal Perfusion in MPO-immunized and 
Control-immunized Rats 
Urine Analysis.  Rats perfused with the lysosomal extract 
with or without H202 or MPO in combination with H202 
(groups I-IV) had proteinuria (Fig. 4), and severe hematuria 
(80% of all those rats) or erythrocyturia (20% of all those 
rats) during the first 24 h  after perfusion. There were no 
significant differences in levels of proteinuria between groups 
I-IV by anova. At 4 and 10 d after perfusion rats from groups 
I-IV were no longer proteinuric (Fig. 4), but severe hematuria 
and erythrocyturia remained in 20-40%, respectively, of all 
those rats.  Rats perfused with H202 alone (group V;  Fig. 
4) and rats perfused with MPO alone (groups VI and VII; 
results not shown) had no proteinuria. 
Deposition of MPO, IgG, and Complement.  At 4  h  after 
perfusion MPO was present in a granular pattern along the 
GBM (Fig.  5 A) in all MPO-immunized rats (Table 2).  By 
immunoelectron microscopy (IEM) we observed that at 4 h 
after perfusion MPO was localized at the subendothelial and 
subepithelial side of the GBM (Fig. 5 B). In control-immunized 
rats (groups II and VII) MPO could not be detected along 
the GBM.  In MPO-immunized rats IgG and complement 
were present along the GBM in a granular pattern along the 
GBM at 4 h after perfusion. At 24 h  MPO was no longer 
present in group I rats,  whereas IgG and complement C3 
could still be detected in a diffuse granular pattern along the 
GBM (Fig. 5, C and D). In the remaining MPO-immunized 
rats (groups III, IV,  and VI) MPO as well as IgG and C3 
Figure 2.  Immunoprecipitation  studies with a crude  neutrophilic  pro- 
tein extract. Lanes  A-D contain the characteristic MPO bands (55 and 
39 kD) precipitated  by rat IgG, obtained at 10 wk after immunization 
with MPO. Sera  from  control  immunized  rats did not precipitate  any pro- 
teins (lane F). Lane  E shows also the 55- and 39-kD bands precipitated 
by a polyclonal  anti-MPO antibody.  This polyclonal  antibody  also recog- 
nizes smaller MPO fragments. 
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Figure 3.  Skin  tests  in control  (n = 3) and MPO-immunized  rats (n = 9) 
at 1, 5, and 10 wk after immunization. Ear thickness was measured in 
triplicate at 4, 24, and 48 h after  injection  of 10/~1 heat-inactivated  MPO 
solution subcutaneously  in the inner ear pinna. Increase  in ear thickness 
was measured  with an engineer's  micrometer.  Results represent  mean -+ 
SEM. 
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Figure  4.  Urine analysis  performed 1 wk before perfusion, and 24 h, 
4 d, and 10 d after perfusion.  Proteinuria was estimated with the biuret 
method and results are presented as mean  _+  SEM. Group I, MPO im- 
munized  and  perfused  with  the lysosomal  enzyme  extract  and  H202 
(n  ffi 17); group II, control immunized and perfused with the lysosomal 
enzyme extract and HzO2 (n  ffi 9); group III, MPO immunized and per- 
fused with the lysosomal enzyme extract (n  ~  5); group IV, MPO im- 
munized and perfused with MPO and H202 (n  ffi 8); and group V, MPO 
immunized  and perfused with H202 (n  ffi  4). 
were still detectable (Table 2). At 4 and 10 d after perfusion 
deposits of IgG and complement were scanty or had disap- 
peared completely in rats immunized with MPO and per- 
fused with the lysosomal extract and H202 (group I; Table 
2 and Fig. 5, E and F). In contrast, deposits of IgG and C3 
were still present in MPO-immunized rats perfused with the 
lysosomal extract  without  H202  (group  III),  MPO  and 
H202 (group  IV),  and MPO alone (group VI) at 4 and 10 d 
after perfusion (Table 2). The right nonperfused kidneys were 
always negative for MPO, IgG, and C3, except for a weak 
mesangial staining for IgG in some of the biopsies. 
Histopathology.  Severe  lesions were only found in rats that 
were immunized with MPO and perfused with the lysosomal 
enzyme extract or MPO and H202 (groups I and IV). At 
24 h the main abnormalities detected in the per'fused  left kidney 
consisted of wrinkling of the GBM,  accumulation of eo- 
sinophilic proteinaceous material into the capillary lumen and 
Bowman's space, glomerular capillary  wall necrosis,  PAS- 
positive reabsorption droplets in the cytoplasm of proximal 
convoluted tubules, and numerous urinary casts in tubular 
lumina (Fig. 6 A). At day 4, severe changes were seen in the 
renal  cortex.  30-80%  of the glomeruli showed fibrinoid 
necrosis of glomerular capillary walls, intra- and extracapil- 
lary cell proliferation, ruptures in Bowman's capsule, and influx 
of mononuclear ceils and PMN. Periglomerular 'granuloma- 
like' infiltrates  were seen consisting of mononuclear cells, 
PMN, and giant cells. At day 10 active, inflammatory lesions 
were still present. Intra- and extracapiUary cell proliferation 
was found in 30-70%  of glomeruli and was accompanied 
by ruptures in Bowman's capsule, periglomerular cell infiltra- 
tion, and giant call formation (Fig. 6, B-D). The interstitium 
showed chronic infiltrates consisting of mononuclear cells and 
PMN that surrounded tubuli and vessels at day 4 and even 
more at day 10 (Fig. 6 E). In addition vasculitis of small venules 
and arteries was observed (Fig. 6 F). In one biopsy we found 
a larger vessd surrounded by PMN and karyorrhectic frag- 
ments (Fig.  6 G). 
In control-immunized  rats perfused with the lysosomal en- 
zyme extract and H202 (group II), we also found accumu- 
lation of eosinophilic proteinaceous material into the capil- 
lary lumen, at 24 h after perfusion, but no development of 
NCGN. In MPO-immunized rats perfused with the lysosomal 
enzyme extract or MPO alone (groups III and VI), no signifi- 
cant lesions were observed, except for periodic acid Shift-posi- 
tive droplets in the cytoplasm of proximal tubuli and a slight 
interstitial infiltrate.  MPO-immunized rats  perfused with 
Table  2.  Intraglomerular Deposition of MPO, IgG, and (7,3 in Rats Killed 24  h, 4 d, and 10 d after Perfusion 
MPO  IgG  C3 
Groups  4h  24h  4d  10d  4h  24h  4d  10d  4h  24h  4d  10d 
I  +  -  -  -  ++  +  -  -  +  +  -  - 
II  ............ 
III  +  +  -  -  +  +  +  +  +  •  +  +  +  +  -+ 
IV  +  -+  -  -  ++  ++  ++  +  ++  +  ++  + 
V  ND  ND  ND  -  ND  ND  ND  -  ND  ND  ND  - 
VI  ++  +  +  -  ++  +++  ++  ++  ++  ++  ++  ++ 
VII  ............ 
Group I, MPO immunized and perfused with the lysosomal enzyme extract and HzO2 (n  ffi  19);  group II, control immunized and perfused with 
the lysosomal enzyme extract and H202  (n  ffi  11);  group III, MPO immunized and perfused with the lysosomal enzyme extract (n  ffi  9); group 
IV,  MPO  immunized  and perfused with  MPO  and H~O2 (n  =  12);  group  V,  MPO  immunized  and perfused with  H202  (n  ~  4);  group  VI, 
MPO immunized and perfused with MPO (n  ffi 8); group VII, control immunized and per'fused  with MPO (n  ffi  5). The amount ofMPO,  IgG, 
and complement deposition was estimated on a semiquantitative (3+)  scale:  -,  absent;  _+, weak;  +,  mild;  +  +, intermediate;  +  +  +,  strong. 
909  Brouwer et al. Figure  5.  Localization of MPO by immunofluorescence and electron microscopy. (A) Staining for MPO in a granular pattern  along the GBM, 
4 h after perfusion with MPO alone in MPO-immunized rats (￿  (/3) Electron microscopic localization of MPO, 4 h after perfusion with MPO 
alone in MPO-immunized rats, on the subendothelial and snbepithelial sides of the GBM (Ep, epithelial side; En, endothelial side) (x30,000).  (C) 
Staining for IgG in a granular pattern along the GBM, 24 h after perfusion with the lysosomal extract and H202 in MPO-immunized rats (x320). 
(D) Staining for complement in a granular pattern along the GBM, 24 h after perfusion with the lysosomal extract and H202 in MPO-immunized 
rats (x 320). (E) Absence of IgG deposits in the presence of active proliferative lesions, 10 d after perfusion with the lysosomal extract and H202 in 
MPO-immunized rats (x320).  (F) Overview shows a glomerulus negative for IgG and tubuli with IgG-positive casts, 10 d after peffusion with the 
lysosomal extract and H202 in MPO-immunized  rats (x200). 
H202  (group V)  or control-immunized  rats perfused with 
MPO  (group  VII) developed  no  lesions  at  all. 
Immunopkenotyping.  In accordance with the findings by 
light microscopic examination, immunophenotyping of renal 
tissue from group I  and IV rats showed larger numbers  of 
intraglomerular,  endo-, and extracapillary macrophages and 
PMN at days 4 and 10 (Table 3). The amount of macrophages 
found in the interstitium gradually increased (Table 3). T  cells 
were observed in  small numbers  within  the glomeruli  and 
more abundantly within the interstitium at day 10 (Table 3). 
910  An Animal Model of Antimyeloperoxidase-associated  Glomerulonephritis Table  3.  lntraglomerular  and Interstitial  Presence of Macrophages,  Neutrophils,  and  T  Cells,  as Detected by the  mAbs  ED1,  His 48, 
and  0X19,  respectively 
Intraglomerular cells*  Interstitial  cellsr 
Infiltrating 
cells  Groups  24  h  4 d  10 d  24 h  4 d  10 d 
PMN  I  1.9  _+  0.2  7.4  _+  4.2  4.1  _+  2.3*  + +  + +  +  +  _+ 
II  0.8  _+  0.2  0.9  +  0.5  0.8  _+  0.2  +_  +_  +_ 
III  1.7  +  0.1  0.6  _+  0.1  0.4  _+  0.2  +  +  -  - 
IV  1.3  _+  0.1  6.3  _+  3.2  1.3  +  1.1  + +  +  + +  + 
V  ND  ND  0.6  -+  0.2  ND  ND  - 
Mono's  I  3.0  +  0.3  16.0  _+  8.1 s  12.4  _+  6.3"  +  + +  +  +  + + 
II  0.5  _+  0.2  1.2  _+  0.2  2.1  +  0.7  -  _+  + 
III  1.5  _+  0.3  1.4  +  0.1  0.2  _+  0.2  +  +  +  + 
IV  0.8  _+  0.1  15.1  +  9.6  15.6  _+  6.4  +  +  +  +  +  +  + 
V  ND  ND  0.3  _+  0.3  ND  ND  - 
T  cells  I  0  0.1  _+  0.1  0.2  +  0.1s  -  -  + + 
II  0  0  0  -  -  - 
III  0  0  0  -  -  _+ 
IV  0  0  0.6  _+  1.0  -  -  +  + 
V  ND  ND  0  ND  ND  - 
Rats were killed at 24 h, 4 d, and 10 d after perfusion. Group I, MPO immunized and perfused with  the lysosomal enzyme extract and HzOz 
(n  =  17); group I1, control immunized and perfused with the lysosomal enzyme extract and HzOz (n  =  9); group III, MPO immunized and per- 
fused with the lysosomal enzyme extract (n  =  7); group IV, MPO immunized and perfused with MPO and H202 (n  =  10); and group V, MPO 
immunized and perfused with  H202 (n  =  4). 
" For estimation of the number of PMN, monocytes, and T cells, we calculated the mean number of cells per glomerulus by counting all positive 
cells present within 50 glomeruli and dividing the total number by 50.  Numbers represent mean _+ SEM. 
Labeled interstitial leukocytes were quantified by using a semiquantative method:  -, absent; _+, minimal; +, mild; + +, moderate; and  + + +, 
severe. 
S/, <(0.05 compared with  groups II, III, and IV. 
Mild infiltration  of inflammatory cells was found in group 
VI at 24 h and 4 d after perfusion (data not shown). In accor- 
dance with  the absence of IgG or complement deposits  at 
the time of active fulminant  NCGN, we found no correla- 
tion between  the presence of IgG or complement  and  the 
amount  of infiltrated  macrophages  and  PMN. 
Discussion 
This study describes the first animal model that allows us 
to  study  the  pathogenesis  of anti-MPO-associated  pauci- 
immune NCGN.  The model is based on immunization of 
rats with MPO and subsequent  localization of a lysosomal 
extract,  primarily consisting of MPO and elastinolytic en- 
zymes, in combination with H202,  the substrate  of MPO, 
along  the  GBM.  The  lesions  found  in  this  model  closely 
resemble human anti-MPO-associated NCGN, characterized 
by a lack of Ig deposition at the time of fulminant glomeru- 
lonephritis  (9,  10,  12). 
BN  rats  immunized  with  human  MPO  developed  anti- 
MPO antibodies. The presence of an anti-MPO-directed ira- 
mune response alone did, however, not result in the develop- 
ment of NCGN, as shown by the absence of lesions in the 
nonperfused kidneys.  In human pathology, also,  anti-MPO 
antibodies can be present without disease  activity (21).  In- 
tercurrent infections, resulting in priming of PMN followed 
by further activation and release of enzymes and oxygen rad- 
icals in the presence of anti-MPO antibodies (15), frequently 
precede disease  activity  (22). 
In our hypothesis the (focal) presence of active enzymes 
at the site of the GBM, possibly as a result of focal neutro- 
phil  activation  and  degranulation,  is  a prerequisite  for the 
development of NCGN. For this reason, we chose to perfuse 
the rat  kidney with  a lysosomal extract,  containing MPO 
and elastinolytic enzymes, and H202.  Proteinuria was found 
in rats during the first 24 h after perfusion with the lysosomal 
extract  and  H202  (groups  I  and  II),  and  MPO  and  H202 
(group IV), and was independent of the presence of antibodies 
to MPO.  In accordance, intracapillary eosinophilic deposits 
were found both in MPO-immunized (group I) and control- 
immunized rats (group II) as reported also by Johnson et al. 
(19,  23).  Perfusion with  the lysosomal extract  (group III), 
containing elastinolytic enzymes capable of GBM degrada- 
911  Brouwer  et al. Figure  6.  Light microscopy of lesions found in group I rats (MPO im- 
munized and perfused with  the lysosomal enzyme e~tract and H2Oz); 
methamine~silver with aniline red countersr~inin~. (A) Capil~ties occluded 
with eosinophilic material and tuft necrosis, 24 h after I~'fusion. (B) Cres- 
cent  formation,  tuft  necrosis  (arrow),  gaps in  Bowman's capsule,  and 
periglomerular infiltration, 10 d after perfusion. (C) Intra- and ~tracapil- 
lazy cell proliferation, crescent formation, gaps in Bowman's capsule, and 
periglomerular infiltration, 10 d after perfilsion. (D) Intra- and ~tracapil- 
lazy cell proliferation, periglomerular infiltration,  and giant cell forma- 
tion (arrows), 10 d  after perfusion.  (E) Chronic mononuclear infiltrates 
surrounding glomeruli and tubuli 10 d after perfusion within the inter- 
stitium.  (F) Vasculitis of a small venule with perivascular slightly granuloma- 
tons infiltration of monocytes, iymphocytes, giant cells, and PMN,  10 d 
after perfusion. (G) Karyorrhectic fragments surrounding  a larger renal 
artery (A-D, F, and G,  x560;  E,  x225). 
912  An Animal Model of Antimyeloperoxidase-assodated Glomerulonephritis tion (24), alone also resulted in proteinuria during the first 
24 h after perfusion. A direct toxic effect of MPO/H202 or 
elastinolytic degradation  of the GBM by perfused elastino- 
lytic enzymes seems to be responsible for the proteinuria found 
in those groups of rats.  Only rats immunized  with  MPO 
and perfused with  the lysosomal enzyme extract  or MPO 
plus H202 developed proliferative  lesions.  The earliest lesions 
consisted of intracapillary  deposition of eosinophilic mate- 
rial. Subsequently glomerular capillary wall necrosis, fibrinoid 
necrosis, intra- and extracapillary cell proliferation, fragmen- 
tation of Bowman's capsule, periglomerutar "pseudogranu- 
loma" formation,  and chronic interstitial inflammation  and 
vasculitis were found. IgG and C3 deposits were no longer 
present at the time when these active inflammatory lesions 
had developed in MPO-immunized  rats perfused with  the 
lysosomal extract and H202. Control-immunized  rats,  per- 
fused with the lysosomal enzyme extract and H202, devel- 
oped only intracapillary eosinophilic deposits and mild glo- 
merular infiltration, but no proliferative lesions in accordance 
with Johnson et al. (19, 23). Active MPO, which produces, 
in concert with H202, toxic hydroxylradicals and hypochlo- 
rite (25, 26), was shown to be present for a longer time period 
in MPO-immunized rats than in control-immunized rats (27). 
This probably contributes  to the more extensive morpho- 
logic  damage  found  in  MPO-immunized  rats.  Whereas 
significant  lesions were observed also in MPO-immunized 
rats perfused with MPO and H202, IgG and C3 were still 
present in these rats 10 d after perfusion. Probably, the pres- 
ence of lytic enzymes in the perfusate is related to the disap- 
pearance of IgG and C3 from the GBM. Since toxic oxygen 
metabolites locally inactivate oL-l-antitrypsin,  the major in- 
hibitor of elastinolytic enzymes (26, 28), those enzymes have 
the opportunity to degrade the GBM focally at the site of 
their release and are probably responsible for the fast removal 
of IgG and C3 in rats perfused with the lysosomal extract 
and H202 resulting in the pauci-immune aspect of NCGN. 
The contribution of MPO-specific T ceils to the progression 
of lesions  still  has  to be investigated  (29). 
In conclusion, we have developed the first model for anti- 
MPO-associated pauci-immune glomerulonephritis, in which 
the focal presence of products from activated neutrophils (i.e., 
MPO, its substrate H2Oz, and lytic enzymes) in the presence 
of an anti-MPO-directed immune response is a prerequisite 
for the development  of pauci-immune  NCGN. 
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